Categories
Politics

In a Milestone, Schumer Will Suggest Federal Decriminalization of Marijuana

WASHINGTON — Senator Chuck Schumer of New York plans to propose legislation on Wednesday to decriminalize marijuana at the federal level, putting his weight as majority leader behind a growing movement to unwind the decades-old war on drugs.

The draft bill, called the Cannabis Administration and Opportunity Act, would remove marijuana from the Controlled Substances Act and begin regulating and taxing it, placing federal rules on a burgeoning industry that has faced years of uncertainty. Though states would still be allowed to set their own marijuana laws, businesses and individuals in states that have legalized its use would be free for the first time to sell and consume it without the risk of federal punishment.

The proposal would also try to make recompense to communities of color and the poor for damage from years of restrictive federal drug policy. It calls for immediately expunging nonviolent marijuana-related arrests and convictions from federal records and would earmark new tax revenue for restorative justice programs intended to lift up communities affected by “the failed federal prohibition of cannabis.”

The bill aims to “finally turn the page on this dark chapter in American history and begin righting these wrongs,” said Senator Cory Booker, Democrat of New Jersey, who wrote the bill with Mr. Schumer and Senator Ron Wyden, Democrat of Oregon and the chairman of the Finance Committee.

The legislation faces an uphill battle in the Senate, where Republicans are opposed, and it is unlikely to become law in the near future. President Biden has not endorsed it, and some moderate Democrats are likely to balk at the implications of decriminalizing a drug that has been policed and stigmatized for so long.

But in the arc of the public’s rapid reconsideration of marijuana laws, the presentation on Wednesday was a remarkable milestone for legalization proponents. The suggestion that the Senate’s top leader and the chairman of the powerful Finance Committee would sponsor major decriminalization legislation would have been fantastical in the not-too-distant past.

In a speech on April 20, the unofficial holiday for marijuana smokers, Mr. Schumer said he was trying to prod Washington off the sidelines of a debate in which much of the country was already engaged. Public opinion polling suggests that nearly 70 percent of Americans support legalizing marijuana. Thirty-seven states and the District of Columbia have legalized marijuana for medical use, and 18 states plus D.C. allow recreational use by adults.

Mr. Schumer has also made no secret that he believes Democrats stand to benefit politically from embracing the legalization push, particularly with young voters.

“Hopefully, the next time this unofficial holiday of 4/20 rolls around, our country will have made progress in addressing the massive overcriminalization of marijuana in a meaningful and comprehensive way,” he said in April.

The senators were expected to detail their plans later Wednesday morning at a news conference at the Capitol.

Updated 

July 13, 2021, 8:18 p.m. ET

They are expected to propose empowering the Food and Drug Administration and the Alcohol and Tobacco Tax and Trade Bureau at the Treasury Department to begin regulating the production, distribution and sale of marijuana, removing the Drug Enforcement Administration from its current oversight role. Among other implications, the changes would allow marijuana companies already operating in states where it is legal to gain full access to the United States banking system.

The legislation would gradually institute a federal excise tax like the one on alcohol and tobacco sales, eventually as high as 25 percent for big businesses, allowing the federal government to benefit from sales that came close to $20 billion in 2020. The revenue would then be funneled back to communities most affected by federal drug policy and to fund expanded medical research into cannabis that is currently limited by its status as a controlled substance.

One provision, for instance, would establish a cannabis justice office at the Justice Department to help fund job training, legal aid and help with re-entry after incarceration. Another program would promote loans to small cannabis businesses owned by members of racially or economically marginalized groups to try to ensure that communities that suffered disproportionately under the war on drugs are not left out of the gold rush that has accompanied legalization.

But the bill would aim to make other, more direct attempts to compensate for the impacts of years of aggressive policing. In addition to expunging past arrests and convictions, it would entitle those who are currently serving sentences for nonviolent federal drug crime to a court hearing to reconsider their sentences. And if enacted, the federal government would no longer be able to discriminate against marijuana users seeking federal housing, food or health benefits.

The Democratic-led House passed similar legislation in December, with a handful of Republicans joining to vote in favor. The vote was the first and only time either chamber had endorsed the legalization of cannabis, but the bill died at the end of the last Congress. House leaders plan to pass an updated version in the coming months.

Passage through the Senate is likely to be more tricky. Mr. Schumer would need to assemble 60 votes, meaning he would need the support of at least 10 Republicans. Though libertarian-leaning Republicans have generally supported ending the prohibition of marijuana, party leaders are likely to oppose the Democrats’ plan, particularly with its emphasis on restorative justice and government intervention in the cannabis industry.

But opposition is not limited to Republicans. Mr. Schumer would have to persuade moderate Democrats who are uncomfortable with the implications of decriminalization to support it.

Mr. Biden supports decriminalizing marijuana and pulling back the war on drugs, but his views are generally more conservative than many Democrats’ and he has not endorsed Mr. Schumer’s proposal. His White House made headlines this spring for pushing out five staff members over their use of marijuana.

Categories
Politics

Supreme Court docket Justice Clarence Thomas says federal marijuana legal guidelines could also be outdated

Clarence Thomas, Assistant Justice of the U.S. Supreme Court, listens during a ceremony on the South Lawn of the White House in Washington, DC, the United States, on Monday, October 26, 2020.

Al Drago | Bloomberg | Getty Images

Supreme Court Justice Clarence Thomas said Monday that federal laws against the sale and cultivation of marijuana are inconsistent, making a national ban unnecessary.

“A ban on the interstate use or cultivation of marijuana may no longer be necessary or appropriate to support the federal government’s piecemeal approach,” wrote Thomas, one of the court’s most conservative judges, in a statement.

The court’s decision not to hear a new case related to tax deductions alleged by a medical marijuana dispensary in Colorado prompted Thomas to issue a statement relating more broadly to federal marijuana laws.

Thomas stated that a 2005 judgment in the Gonzales v. Raich, which stated that the federal government could enforce the ban on marijuana possession, may be out of date.

“Federal policy over the past 16 years has severely undermined its rationale,” added Thomas. “The federal government’s current approach is a half-in, half-out regime that both tolerates and prohibits the local use of marijuana.”

Thomas referred to several guidelines that contradict the 2005 ruling. These include Justice Department memoranda from 2009 and 2013 stating that the government would not interfere with state marijuana legalization programs or prosecute individuals for marijuana activities if it was in accordance with state law.

He added that since 2015, Congress has repeatedly banned the Justice Department from using federal funds to meddle in the implementation of state medical marijuana laws.

“Given all these developments, one can understand why a normal person might think that the federal government has withdrawn from its once absolute ban on marijuana,” he wrote.

With 36 states allowing medical marijuana use and 18 recreational use, Thomas claimed marijuana companies do not experience “equal treatment” under the law.

The problem is a provision in tax law that prohibits companies that deal in marijuana and other controlled substances from deducting their business expenses. The IRS is cracking down on marijuana companies like the Colorado medical marijuana dispenser by conducting investigations into their tax deductions.

“Under this rule, a company that is still in the red after paying its workers and leaving the lights on could still owe a sizable federal income tax,” wrote Thomas.

The judiciary also found a consequence of the federal marijuana ban, stating that most marijuana companies operate entirely in cash due to restrictions preventing state financial institutions from providing banking services to these companies. This makes these companies more vulnerable to break-ins and robberies, according to Thomas.

All of these questions regarding federal marijuana laws threaten, Thomas argues, the principles of federalism.

“If the government is now satisfied with allowing states to ‘act as laboratories, then it may no longer have authority to enter the[t]The central police powers of the states. . . Define criminal law and protect the health, safety and wellbeing of its citizens, “said Thomas.

Legal experts like Joseph Bondy, a cannabis law expert on the board of directors of the National Organization for the Reform of Marihuana Laws, agreed with the judiciary’s testimony, predicting that arguments about the injustice of federal marijuana laws would continue. Law & Crime reported on Monday.

While Bondy noted that Thomas’ testimony may not have actual legal implications, he told Law & Crime that it was still “sending out a message that may temper the views of some people in Congress,” including “one of our Republican senators.” “

Categories
Politics

Schumer requires marijuana to be decriminalized by subsequent 12 months’s 420

A man displays medical marijuana from a Massachusetts medical marijuana dispensary in Salem.

Jonathan Wiggs | The Boston Globe | Getty Images

Senate majority leader Chuck Schumer on Tuesday reiterated his call to legalize marijuana at the federal level, saying he hopes to end the drug ban by April 20 next year.

“Hopefully next time, when this unofficial holiday, April 20th, is over, our country will have made progress in a meaningful and comprehensive fight against the massive over-criminalization of marijuana,” said Schumer on the floor of the upper chamber.

Schumer said the nation’s war on drugs “too often has been a war against people, especially those of skin color”.

“I believe the time has come to end the federal marijuana ban in this country, and I’m working with Sens. Booker and Wyden on laws to do just that,” he said.

In February, Schumer and Sens. Cory Booker, DN.J., and Ron Wyden, D-Ore., Published a joint statement calling for restorative justice for people convicted of pot-related crimes.

Senators then said they would release “a single draft discussion on major reforms” earlier this year and that passing the law would be a priority for the Senate. The draft has yet to be published.

The House recently passed law allowing banks to work with cannabis companies in states where cannabis is legal. This was seen as a move to allow more commercial use by the federal government.

This legislation is now awaiting Senate approval.

To date, 15 states and the District of Columbia have legalized marijuana for recreational adult use, and 36 states allow the drug to be used medicinally.

Categories
Health

New Mexico Is Set to Legalize Leisure Marijuana

New Mexico was set to be the 16th state to legalize recreational marijuana after lawmakers passed a bill on Wednesday that joined a national movement to reconsider anti-drug laws that are increasingly seen as obstacles to racial justice and the economy.

Governor Michelle Lujan Grisham, a Democrat, said she would sign the bill, which would also clear criminal records of people who owned marijuana for personal use. She said in a statement that workers, entrepreneurs and the government will benefit from the new industry, creating jobs and tax revenue.

“And those harmed by this country’s failed drug war, disproportionate color communities, will benefit from our state’s smart, fair and equitable new approach to previous low-level convictions,” she said.

The bill was passed the same day that New York State legalized recreational marijuana. Lawmakers in both states said they were motivated to create a legal, tax-revenue-generating industry that used to run underground and end the arrests for low-level crimes.

New Mexico law allows people over 21 to ingest up to two ounces of marijuana, and individuals can have six plants at home, or up to 12 per household. The sale would begin in April 2022 at the latest and be taxed at 12 percent, eventually at 18 percent plus gross income taxes.

According to a tax analysis quoted by the Albuquerque Journal, the industry is government regulated and will generate estimated revenues of $ 20 million for the state and $ 10 million for local governments in 2023.

The New Mexico move is part of a growing consensus in the United States in favor of decriminalizing marijuana. According to the Pew Research Center, 91 percent of Americans support legal medical or recreational use in 2019. Voters in Arizona, Montana, New Jersey and South Dakota voted to legalize recreational marijuana in November, while Mississippi and South Dakota became the 34th and 35th states to allow medicinal marijuana.

New Mexico law ignored Republican objections, but not all opposed legalization. Some only argued over the details, including how the industry would be taxed, licensed, and regulated.

Supporters including Emily Kaltenbach, Senior Director for States of Residence and New Mexico for the Drug Policy Alliance, welcomed the passage of the bill.

“Today’s adoption of the cannabis legalization and expulsion package will ensure equitable opportunities and long overdue justice – including automatic expulsion – for farmers and other small businesses – for those with previous cannabis arrests or convictions,” she said in a statement.

According to The Associated Press, around 100 prisoners will have their sentences reconsidered under the new law.

Categories
Business

New York state legislature passes invoice to legalize leisure marijuana

New York lawmakers passed a law to legalize recreational marijuana on Tuesday, and Governor Andrew Cuomo said he would sign it.

The Senate voted 40-23 to pass the laws. Later that evening, the State Assembly voted 100-49 for the bill.

If the bill is signed, the Empire State, along with the District of Columbia, will be the 15th state in the country to legalize the drug for recreational use.

“For too long, the cannabis ban has disproportionately targeted color communities with harsh sentences, and after years of hard work, this landmark piece of legislation provides justice for long-marginalized communities, embraces a new industry that is growing the economy, and creates significant security for the public” said Governor Andrew Cuomo in a statement Tuesday evening after the bill was passed.

“I look forward to including this legislation in the law,” he said.

New York Mayor Bill de Blasio said he supported legislation based on racial justice. “I think this bill goes a long way. I think there is still a lot to be done, but there is a long way to go,” said de Blasio, according to WDTV ABC 11.

Black and Latin American New Yorkers together accounted for 94% of marijuana-related arrests by the New York City Police Department in 2020, although city statistics show that the proportion of white New Yorkers who use marijuana is significantly higher than that Latino or black residents. According to a survey by the New York Department of Health, 24% of white residents reported using marijuana, compared with 14% of black and 12% of Latin American residents in the 2015-2016 biennium, the latest available data.

Weed legalization vote comes after neighboring New Jersey state recently legalized the plant. The aim of the legislature was to pass the law as part of the state budget before April 1st.

The bill was sponsored by Senator Liz Krueger and Congregation Majority Leader Crystal Peoples-Stokes. The Senators debated for three hours, with Republicans claiming the bill was dangerous and not what all New Yorkers wanted.

“We met endlessly with everyone who asked us,” replied Krueger during the procedure. “The truth is, I’m not sure I have ever met such a diverse group of people as in the seven years my chief of staff and I worked on this bill.”

The legalization is expected to ultimately generate billions in revenue for the state, and New York City in particular, with a hefty 13% tax that includes a 9% state tax and 4% local tax. The measure also includes a potency tax of up to 3 cents per milligram of THC, the natural psychoactive component of marijuana that supplies the plant high.

An estimate by Cuomo’s office predicts that annual tax revenues from legal weed sales could add $ 350 million a year and 60,000 jobs to the state once the industry is fully established.

The measure allows possession of up to 3 ounces of marijuana and 24 ounces of marijuana concentrate, and allows up to six plants to be grown at home.

The legislation also provides equity programs to provide loans and grants to people, including smallholders, disproportionately affected by the war on drugs.

“My goal in implementing this legislation has always been to end the racially diverse enforcement of the marijuana ban that has weighed so heavily on color communities in our state, and to use the economic wind of legalization to heal and repair those same communities to contribute. ” “Said Kruger in a press release.

“I’ve seen such injustices and for young people whose lives have been destroyed because they did something I did as a kid,” Krueger said as she recorded her voice for the measure. “Nobody put a gun to my head and nobody tried to put me in jail for being that nice white girl.”

Some officials are even calling for the bill to fund universal basic income programs and home ownership for communities hardest hit by the drug war.

“With the impending legalization of marijuana, we have the opportunity to legislate locally to bring the concept of redress through a UBI and home ownership to life for Rochester and its families,” said Rochester, New York, Mayor Lovely Warren of Rochesterfirst .com.

The bill will clear the criminal records of tens of thousands of people, aim to reinvest 40% in color communities, and give 50% of adult use licenses to social justice applicants and small business owners.

The law also “creates a well-regulated industry to ensure that consumers know exactly what they are getting when they buy cannabis”.

The move creates a cannabis management bureau, which is an independent agency working with the New York State Liquor Authority. The agency would be in charge of regulating the recreational cannabis market and existing medical cannabis programs. The agency would also be overseen by a cannabis oversight committee made up of five members – three appointed by the governor and one each appointed by the Senate and the State Assembly.

Police groups and the New York Parent-Teacher Association have openly expressed concern about the bill.

“Absolute travesty. All of the research submitted shows it’s harmful to children and makes the streets less safe,” said Kyle Belokopitsky, New York State PTA Executive Director, ABC 7 New York. “And I have absolutely no idea what lawmakers think when they think they want this to happen now.”

New York officials are launching an education and prevention campaign to reduce the risk of cannabis use in school-age children, and schools can participate in drug prevention and awareness programs. The state will also start a study looking at the effects of cannabis on driving.

The law allows municipalities to pass laws that prohibit cannabis dispensaries and consumption licenses. The deadline is nine months after legalization.

If the bill is signed, legalization of the facility would take effect immediately, but legal recreational sales would not be expected to begin for a year or two.

– CNBC’s Lynne Pate contributed to this report.

Categories
World News

A Inexperienced Wave? Mexico’s Marijuana Market Could Be Middling

MEXICO CITY – Mexico, a country that has been shaped by cartels for decades, is about to take an important step in drug policy. This week the House of Commons approved a landmark law legalizing recreational marijuana that would make it the world’s largest legal drug market.

Given that legalization is far from certain to garner Senate and President approval, many in the business world are predicting a Mexican green boom: a newly legal industry, tens of thousands of jobs, millions of dollars in profits for savvy entrepreneurs and welcome tax revenue for the US government.

However, many business analysts and economists are cautious, warning that the cannabis industry here is more of a green slip than a boom. The opening of a legal market is more legal and symbolic than economic in nature, they argue, citing relatively low domestic demand and low export opportunities for the product as well as seemingly restrictive regulatory measures.

“It’s hard to see any obvious far-reaching implications for the Mexican economy,” said Jeffrey Miron, an economist at Harvard University. “You will see a small drag on measured GDP,” he added, “but the people who claim that legalization will make this a big boost to the economy make no sense at all.”

But industry sponsors are excited about the prospects.

The cannabis industry “is finally going to generate income in terms of employment, in terms of the local economy, in terms of taxes,” said Erick Ponce, a Mexican entrepreneur and president of the Cannabis Industry Promotion Group, a local research and advocacy group.

“We definitely see it as a major economic boom for the country, especially in the middle of a pandemic,” added Ponce.

The Mexican marijuana industry could be worth up to $ 3.2 billion annually, and big cannabis companies like Canada’s Canopy Growth are already watching the market, according to a January report by a cannabis data analytics firm, New Frontier Data.

But Canada can be a cautionary story. Ahead of its own legalization in 2018, investors and analysts predicted a surge in cannabis cash, but the deal was not a sweeping success.

In the final quarter of 2020, the country’s national statistics agency estimated that consumers were spending Canadian $ 918 million (about $ 736 million) on legal weed products, significantly less than predicted prior to legalization. The result was sluggish and most manufacturers are still reporting losses running into the millions. In December, Canopy Growth announced it was closing five facilities and laying off more than 200 employees to accelerate profitability.

“The green rush part didn’t happen,” said Michael Armstrong, associate professor at the Goodman School of Business at Brock University in Ontario. “It was a positive boost for Canada, but by no means a dramatic one.”

Official figures show that Canada, with a much smaller population, has many more regular users than Mexico: Before legalization, around 15 percent of Canadians said they had smoked marijuana in the past three months, according to the national statistics bureau, a consumer base of more than 5 million potential users.

In contrast, a 2016 study by the Mexican government found that only about 1.2 percent of the population aged 12 to 65 said they had smoked a pot in the previous month, and 2.1 percent, about 1.8 Million, last year.

Legalization advocates argue that such numbers are misleading: in a country like Mexico, where the majority of the population is against weed legalization, many people do not admit to smoking it.

“Cannabis is a problem with stigma, with taboo,” said entrepreneur Ponce. “We don’t really know the impact of the local market because there are no real statistics.”

But even if surveys underestimate the number of potential consumers, most experts downplay the size of the market in Mexico.

“I don’t think there will be much demand,” said Jorge Javier Romero Vadillo, political scientist at the Autonomous Metropolitan University in Mexico. And “I don’t think this regulatory process will significantly increase demand.”

Romero said the new law’s stringent licensing requirements for the cultivation, packaging and sale of marijuana could keep smallholders and sellers out of the legal market.

“With the rules they want to apply, which are very restrictive, they are going to open a tiny market,” he said. “They are rules that are so strict, with a barrier to entry that is so high that few will choose to enter the legal market.”

California, which legalized recreational marijuana in 2018, had similar teething troubles: In the first year of legalization, legal vendors in the state sold $ 500 million less than the previous year when it was licensed for medical use only.

According to Daniel Sumner, director of the Center for Agricultural Issues at the University of California at Davis, strict regulations and high taxes kept the majority of California producers and sellers in the gray or black market. In many communities, marijuana-related businesses have faced severe local opposition.

Sales have increased significantly recently as the number of licensed growers and vendors has gradually increased and the state introduced cannabis taxes of $ 1 billion last year, according to Sumner.

“It’s a formidable business,” he said, but “it’s a drop in the ocean” in the context of California’s annual budget of more than $ 200 billion.

With a relatively small consumer base and complex regulatory measures, Mexico’s recreational market is unlikely to come close to that, analysts say.

Instead, some industry leaders say the real money in Mexico may be in medical cannabis, which has been legal in Mexico since 2017, as well as industrial hemp, which is also regulated in the new bill and could be used to make anything from plastics to paper.

“The marijuana market is a very small market,” said Guillermo Nieto, president of the National Cannabis Industries Association, a Mexico City-based trade group. “Agriculturally, liking industrial hemp legalization won’t help us.”

In the short term, some business people say Mexico’s biggest gains could be doing what Mexico is already best at: manufacturing – in this case, possibly cannabis products such as supplements and cosmetics.

Still, the biggest impact may be more symbolic than monetary: As the largest economy to legalize the drug to date, Mexico, home to around 128 million people, could encourage other countries, including its northern neighbor, to follow suit.

“Sometimes it’s nerve-wracking to be the first to step into a pond that could be infested with sharks,” said Miron, the Harvard professor. “But when four or five other people have done it and it’s okay, more people will try.”

Categories
Health

Medical Marijuana Is Not Regulated as Most Medicines Are

Another marijuana-based drug, Nabiximole (Sativex), is available in Canada and several European countries to treat spasticity and nerve pain in patients with multiple sclerosis.

Medical cannabis is hardly a new therapeutic agent. It was widely used as a patent drug in the United States in the 19th and early 20th centuries and listed in the United States Pharmacopoeia until the passage of the Marijuana Tax Act in 1937 made it illegal.

Then a 1970 federal act made it a Schedule 1 substance that severely restricted access to marijuana for legitimate research. To make matters worse, plants like marijuana contain hundreds of active chemicals, the amounts of which can vary widely from batch to batch. Unless researchers can study purified substances in known quantities, conclusions about benefits and risks are highly unreliable.

As in Dr. Finn’s book, here are some expert conclusions about the role of medical marijuana in their respective fields:

People who use marijuana for pain relief do not reduce their dependence on opioids. In fact, Dr. Finn: “Narcotics patients who also use marijuana for pain say their pain level is still 10 on a scale of 1 to 10.” The authors of the chapter on pain, Dr. Peter R. Wilson, pain specialist at the Mayo Clinic in Rochester, Minnesota, and Dr. Sanjog Pangarkar of the Greater Los Angeles, VA Health Service concluded, “Cannabis itself does not produce analgesia and, paradoxically, it could interfere with opioid analgesia. “A 2019 study of 450 adults in the Journal of Addiction Medicine found that medical marijuana not only did not relieve pain for patients, it also increased the risk of anxiety, depression, and substance abuse.

Dr. Allen C. Bowling, a neurologist at the NeuroHealth Institute in Englewood, Colorado, noted that while marijuana has been extensively studied as a treatment for multiple sclerosis, the results of randomized clinical trials have been inconsistent. The studies overall showed some but limited effectiveness, and in one of the largest and longest studies, the placebo performed better in treating spasticity, pain, and bladder dysfunction, wrote Dr. Bowling. Most of the studies used pharmaceutical grade cannabis that is not available in pharmacies.

The study, which suggests that marijuana could reduce the risk of glaucoma, dates back to 1970. In fact, THC does lower the harmful pressure in the eye, but as Dr. Finny T. John and Jean R. Hausheer, ophthalmologists at the University of Oklahoma Health Sciences Center, wrote, “To achieve therapeutic levels of marijuana in the bloodstream for treating glaucoma, a person would have to smoke approximately six to eight times a day. At that point, the person would likely be physically and mentally incapable of performing tasks that require attention and focus, such as: B. Working and driving. The major medical eye care companies have thumbs down on marijuana as a treatment for glaucoma.

Allison Karst, a psychiatric pharmacy specialist at VA Tennessee Valley Health System who researched the benefits and risks of medical marijuana, concluded that marijuana can have “negative effects on mental health and neurological function,” including deterioration the symptoms of PTSD and bipolar disorder.

Dr. Karst also cited a study that showed that only 17 percent of edible cannabis products were accurately labeled. In an email, she wrote that the lack of regulation “creates difficulties in extrapolating available evidence to different products in the consumer market due to differences in chemical composition and purity”. She cautioned the public not to weigh “both potential benefits and risks,” which I would add a caveat to – buyers beware.